Table 1.
Baseline demographics of patients (n = 16)
| Age, years | 58.9 ± 7.6 |
| Male gender, n (%) | 8 (50) |
| Body mass index, kg/m2 | 24.2 ± 2.0 |
| Aetiology of ESRD, n (%) | |
| Hypertension | 2 (12.5) |
| Diabetes mellitus | 3 (18.8) |
| Glomerulonephritis | 2 (12.5) |
| Polycystic kidney disease | 4 (25) |
| Others | 5 (31.2) |
| Comorbidities, n (%) | |
| Hypertension | 15 (93.8) |
| Diabetes mellitus | 4 (25) |
| Ischemic heart disease | 3 (18.8) |
| Cerebrovascular disease | 1 (6.3) |
| History of malignancy | 5 (31.3) |
| Hemodialysis vintage, years | 3.6 (2.6–7.3) |
| Dialysis access, n (%) | |
| Native fistula | 14 (87.5) |
| Synthetic graft | 2 (12.5) |
Continuous variables are expressed as mean ± standard deviation or median (interquartile range).
ESRD, end-stage renal disease.